Articles from Colossal Foundation
The IUCN Species Survival Commission (SSC) and the Colossal Foundation, the 501(c)(3) nonprofit arm of Colossal Biosciences, today announced a four-year, $4 million partnership to expand the responsible use of advanced technologies in global species conservation. The collaboration pairs more than 11,000 IUCN SSC experts, working through 210 groups in 186 countries, with scientific and technological capabilities from across the Colossal ecosystem, while preserving IUCN SSC's scientific independence and established Red List standards.
By Colossal Foundation · Via Business Wire · September 15, 2026
The Colossal Foundation, the 501(c)(3) charitable organization of Colossal Biosciences, has announced the second cohort of its Species Reintroduction Fund, expanding the program to seven new species across four continents. In collaboration with the global conservation nonprofit Re:wild, the Fund will direct its annual commitment of $250,000 to teams working in Cambodia, the United States, Brazil, Guatemala, Australia, and Canada.
By Colossal Foundation · Via Business Wire · August 6, 2026
A contagious facial cancer has erased roughly 80% of Tasmania's wild devils since it surfaced in the 1990s, and biting, a natural behavior for feeding and mating, spreads it faster than conservation can contain it. The Colossal Foundation, the nonprofit conservation arm of Colossal Biosciences, is now joining the fight. It has partnered with the University of Tasmania to attack Devil facial tumour disease (DFTD) on two fronts.
By Colossal Foundation · Via Business Wire · July 1, 2026
The Colossal Foundation, the 501(c)(3) charitable organization associated with Colossal, the de-extinction company, today announced a $500,000, 5 year commitment to the Turner Endangered Species Fund (TESF) to advance the recovery and rewilding of the Bolson tortoise (Gopherus flavomarginatus), North America’s largest and rarest tortoise species, within its prehistoric range.
By Colossal Foundation · Via Business Wire · November 12, 2025
The Colossal Foundation, the 501(c)(3) charitable organization of Colossal Biosciences, the de-extinction company, today announced the launch of its Species Reintroduction Fund. In collaboration with conservation non-profit, Re:wild, this first-of-its-kind fund will dedicate at least $250,000 annually to support every phase of reintroduction–including planning, genetic assessment and post-release monitoring for threatened species across terrestrial and aquatic ecosystems worldwide.
By Colossal Foundation · Via Business Wire · August 5, 2025